Evidence map›Paper›PMID 25083570›Full record

ReviewBehavioural pharmacology2014

Drug withdrawal conceptualized as a stressor.

Elena H Chartoff, William A Carlezon

Open access · greenAbstract readReview
In one paragraph

Review in Behavioural pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Release of endogenous dynorphin opioids in the prefrontal cortex disrupts cognition.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  10. Identifying Opioid Withdrawal Using Wearable Biosensors.Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats.The international journal of neuropsychopharmacology · 2019
    Article
  16. Article
  17. Sex differences in neural mechanisms mediating reward and addiction.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Review
  18. Review
  19. Effects of Chronic Social Defeat Stress on Sleep and Circadian Rhythms Are Mitigated by Kappa-Opioid Receptor Antagonism.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  20. Cocaine Seeking During Initial Abstinence Is Driven by Noradrenergic and Serotonergic Signaling in Hippocampus in a Sex-Dependent Manner.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Elena H ChartoffDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA.
William A Carlezon
McLean Hospital · US

Funding

Roles of nuleus accumbens CREB and Kappa function in depressionR01MH063266 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI CARLEZON, WILLIAM A. · 2001 to 2025
$9.1M
PACAP signaling in stress and anxietyR01MH097860 · NIMH · MCLEAN HOSPITAL · PI CARLEZON, WILLIAM A. · 2013 to 2016
$1.6M
Role of dopamine signaling in the mood-related effects of salvinorin AR01DA026552 · NIDA · MCLEAN HOSPITAL · PI CHARTOFF, ELENA H · 2010 to 2013
$1.2M
PACAP signaling in stress and anxietyR56MH097860 · NIMH · MCLEAN HOSPITAL · PI CARLEZON, WILLIAM A. · 2012 to 2012
$381k
Role of AMPA receptors in the nucleus accumbens shell in morphine depedenceR03DA023606 · NIDA · MCLEAN HOSPITAL · PI CHARTOFF, ELENA H · 2008 to 2009
$177k
NIDA NIH HHS DA023606NIDA NIH HHS DA026552NIDA NIH HHS R01 DA026552NIDA NIH HHS R03 DA023606NIMH NIH HHS MH063266NIMH NIH HHS MH097860NIMH NIH HHS R01 MH063266NIMH NIH HHS R01 MH097860NIMH NIH HHS R56 MH097860
6 · The paper itself

Abstract

Drug withdrawal is often conceptualized as an aversive state that motivates drug-seeking and drug-taking behaviors in humans. Stress is more difficult to define, but is also frequently associated with aversive states. Here we describe evidence for the simple theory that drug withdrawal is a stress-like state, on the basis of common effects on behavioral, neurochemical, and molecular endpoints. We also describe data suggesting a more complex relationship between drug withdrawal and stress. As one example, we will highlight evidence that, depending on drug class, components of withdrawal can produce effects that have characteristics consistent with mood elevation. In addition, some stressors can act as positive reinforcers, defined as having the ability to increase the probability of a behavior that produces it. As such, accumulating evidence supports the general principles of opponent process theory, whereby processes that have an affective valence are followed in time by an opponent process that has the opposite valence. Throughout, we identify gaps in knowledge and propose future directions for research. A better understanding of the similarities, differences, and overlaps between drug withdrawal and stress will lead to the development of improved treatments for addiction, as well as for a vast array of neuropsychiatric conditions that are triggered or exacerbated by stress.

Indexed as

Models, PsychologicalStress, PsychologicalAnimalsBrainHumansSubstance Withdrawal Syndrome

Identifiers

PMID25083570
PMCPMC4321719
OpenAlexW2410047213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.